Similar articles for PMID: 24246344

Year	Number of Results
1985	1
1989	1
1991	1
2002	1
2004	1
2006	1
2008	2
2009	1
2010	2
2011	5
2012	12
2013	21
2014	24
2015	36
2016	39
2017	33
2018	32
2019	39
2020	27
2021	40
2022	33
2023	42
2024	25
2025	1

1

Reduced risk of hypoglycemia with insulin degludec versus insulin glargine in patients with type 2 diabetes requiring high doses of basal insulin: a meta-analysis of 5 randomized begin trials.

Rodbard HW, Gough S, Lane W, Korsholm L, Bretler DM, Handelsman Y. Rodbard HW, et al. Endocr Pract. 2014 Apr;20(4):285-92. doi: 10.4158/EP13287.OR. Endocr Pract. 2014. PMID: 24246344

2

A Multinational, Randomized, Open-label, Treat-to-Target Trial Comparing Insulin Degludec and Insulin Glargine in Insulin-Naïve Patients with Type 2 Diabetes Mellitus.

Pan C, Gross JL, Yang W, Lv X, Sun L, Hansen CT, Xu H, Wagner R. Pan C, et al. Drugs R D. 2016 Jun;16(2):239-49. doi: 10.1007/s40268-016-0134-z. Drugs R D. 2016. PMID: 27098525 Free PMC article. Clinical Trial.

3

Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes: a 26-week, randomized, controlled, multinational, treat-to-target trial: the BEGIN LOW VOLUME trial.

Gough SC, Bhargava A, Jain R, Mersebach H, Rasmussen S, Bergenstal RM. Gough SC, et al. Diabetes Care. 2013 Sep;36(9):2536-42. doi: 10.2337/dc12-2329. Epub 2013 May 28. Diabetes Care. 2013. PMID: 23715753 Free PMC article. Clinical Trial.

4

PATIENTS ACHIEVING GOOD GLYCEMIC CONTROL (HBA1c <7%) EXPERIENCE A LOWER RATE OF HYPOGLYCEMIA WITH INSULIN DEGLUDEC THAN WITH INSULIN GLARGINE: A META-ANALYSIS OF PHASE 3A TRIALS.

Einhorn D, Handelsman Y, Bode BW, Endahl LA, Mersebach H, King AB. Einhorn D, et al. Endocr Pract. 2015 Aug;21(8):917-26. doi: 10.4158/EP14523.OR. Epub 2015 Jun 29. Endocr Pract. 2015. PMID: 26121451

5

Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials.

Russell-Jones D, Gall MA, Niemeyer M, Diamant M, Del Prato S. Russell-Jones D, et al. Nutr Metab Cardiovasc Dis. 2015 Oct;25(10):898-905. doi: 10.1016/j.numecd.2015.06.005. Epub 2015 Jun 18. Nutr Metab Cardiovasc Dis. 2015. PMID: 26232910 Free article. Review.

6

Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials.

Ratner RE, Gough SC, Mathieu C, Del Prato S, Bode B, Mersebach H, Endahl L, Zinman B. Ratner RE, et al. Diabetes Obes Metab. 2013 Feb;15(2):175-84. doi: 10.1111/dom.12032. Epub 2012 Dec 3. Diabetes Obes Metab. 2013. PMID: 23130654 Free PMC article.

7

[The efficacy and safety of insulin degludec versus insulin glargine in insulin-naive subjects with type 2 diabetes: results of a Chinese cohort from a multinational randomized controlled trial].

Mu YM, Guo LX, Li L, Li YM, Xu XJ, Li QM, Xu MT, Zhu LY, Yuan GY, Liu Y, Xu C, Wang ZJ, Shen FX, Luo Y, Liu JY, Li QF, Wang WH, Lai XY, Xu HF, Pan CY. Mu YM, et al. Zhonghua Nei Ke Za Zhi. 2017 Sep 1;56(9):660-666. doi: 10.3760/cma.j.issn.0578-1426.2017.09.008. Zhonghua Nei Ke Za Zhi. 2017. PMID: 28870034 Clinical Trial. Chinese.

8

Clinical perspectives from the BEGIN and EDITION programmes: Trial-level meta-analyses outcomes with either degludec or glargine 300U/mL vs glargine 100U/mL in T2DM.

Roussel R, Ritzel R, Boëlle-Le Corfec E, Balkau B, Rosenstock J. Roussel R, et al. Diabetes Metab. 2018 Nov;44(5):402-409. doi: 10.1016/j.diabet.2018.02.002. Epub 2018 Feb 19. Diabetes Metab. 2018. PMID: 29548798 Free article.

9

Efficacy and safety of basal insulins in people with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials.

Dehghani M, Sadeghi M, Barzkar F, Maghsoomi Z, Janani L, Motevalian SA, Loke YK, Ismail-Beigi F, Baradaran HR, Khamseh ME. Dehghani M, et al. Front Endocrinol (Lausanne). 2024 Mar 21;15:1286827. doi: 10.3389/fendo.2024.1286827. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38586456 Free PMC article.

10

Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.

Wysham C, Bhargava A, Chaykin L, de la Rosa R, Handelsman Y, Troelsen LN, Kvist K, Norwood P. Wysham C, et al. JAMA. 2017 Jul 4;318(1):45-56. doi: 10.1001/jama.2017.7117. JAMA. 2017. PMID: 28672317 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 24246344

352 results

Results by year